ELYRIA, Ohio, May 20, 2013 (BUSINESS WIRE) -- Robert K. Gudbranson, Senior Vice President and Chief Financial Officer of Invacare Corporation (NYSE:IVC) , will present at the Deutsche Bank Securities, Inc., 38th Annual Health Care Conference in ...
ELYRIA, Ohio, May 13, 2013 (BUSINESS WIRE) -- Invacare Corporation (NYSE:IVC) today announced that the United States Food and Drug Administration (FDA) has found acceptable the Company's first certification audit relating to the qualification and ...
The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 15, 2013 to shareholders of record on July ...
ELYRIA, Ohio, Apr 25, 2013 (BUSINESS WIRE) -- Invacare Corporation (NYSE:IVC) today announced its financial results for the quarter ended March 31, 2013.
ELYRIA, Ohio, May 16, 2013 (BUSINESS WIRE) -- The Board of Directors of Invacare Corporation (NYSE:IVC) announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares ...
Invacare Corp. (IVC, $14.83, +$1.17, +8.57%) said its Taylor Street manufacturing facility in Elyria, Ohio--which is currently subjected to limitations on production due to an FDA consent decree--can resume manufacturing and distributing parts ...
Key players covered include 3M Health Care, Becton, Dickinson and Company, Cardinal Health, Inc., Invacare Corporation, Kimberly-Clark Corporation, Molnlycke Health Care AB and others.
Invacare's revenue was down 4.9% compared to the same quarter last year. Analysts expect that Invacare will post $-0.60 EPS for the current fiscal year.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. To see all exchange delays, please see disclaimer.